Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC

Dermatologic adverse events in the treatment of NSCLC with amivantamab plus lazertinib significantly reduced

Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC

Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Intraoperative radiotherapy for brain tumours

SIOG 2024: Updates in medical oncology

Understanding the role of the Tanzania Medicines and Medical Devices Authority

Advancements in pharmacovigilance in East Africa

Understanding pharmacovigilance in Namibia

Advances in pharmacovigilance in Nigeria

Understanding pharmacovigilance challenges in Lesotho & Swaziland